| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.0K | $6.34M | - | |
| Dir | 24.3K | $4.98M | - | |
| Dir | 13.7K | $2.80M | - | |
| Dir | 9.8K | $2.00M | - | |
| Dir | 8.9K | $1.81M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 2, 2016 | Scangos George A77 | Chief Executive Officer | Sell | 487 | $274.74 | $133,798.38 | -0.8% | |
| Apr 6, 2016 | Koppel Adam | EVP, Strategy And Bus. Dev. | Sell | 102 | $275.00 | $28,050.00 | -5.2% | |
| Apr 6, 2016 | Scangos George A77 | Chief Executive Officer | Sell | 157 | $280.00 | $43,960.00 | -0.3% | |
| Apr 1, 2016 | Scangos George A77 | Chief Executive Officer | Sell | 487 | $258.83 | $126,050.21 | -0.8% | |
| Mar 1, 2016 | Scangos George A77 | Chief Executive Officer | Sell | 487 | $261.37 | $127,287.19 | -0.8% | |
| Feb 25, 2016 | Sandrock Alfred67 | EVP CMO Neuro &Neurodegenerat | Sell | 183 | $261.90 | $47,927.70 | -2.2% | |
| Feb 25, 2016 | Karaboutis Adriana | EVP, Tech, Bus. Sol &Corp Aff | Sell | 84 | $261.90 | $21,999.60 | -1.0% | |
| Feb 17, 2016 | Scangos George A77 | Chief Executive Officer | Sell | 487 | $256.16 | $124,749.92 | -0.8% | |
| Feb 17, 2016 | Sandrock Alfred67 | EVP CMO Neuro &Neurodegenerat | Sell | 722 | $256.16 | $184,947.52 | -8.3% | |
| Feb 9, 2016 | Sandrock Alfred67 | EVP CMO Neuro &Neurodegenerat | Sale+OE | 852 | $246.54 | $210,052.08 | -9.9% |